Icosapent Ethyl Capsule
Product Images NDC 31722-299
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Icosapent Ethyl (NDC 31722-299). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1 120 S (1 120)
Tab 2 (Table 2)
This information provides a comparison between the effects of Cosapent Ethyl at a dosage of 4g/day versus a placebo on various lipid parameters. Baseline values and percentage changes for parameters like TG, LDL-C, Non-HDL-C, TC, HDL-C, VLDL-C, and Apo B are presented for each group. The data is accompanied by confidence intervals to illustrate the differences observed between the groups over the course of the study.*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.